ArticleThe Journal of clinical investigation2025

Inverted chimeric RNAi molecules synergistically cotarget MYC and KRAS in KRAS-driven cancers.

Yogitha S Chareddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.